
| Platform | Pricing | Freemium | Publishes | Daily | |
|---|---|---|---|---|---|
| Issues | 1489 | Founded | a year ago | Last Issue | 3 days ago |
| Active | |||||

October 14, 2026
October 14, 2026
Gilead pays $90M upfront, including equity at a 30% premium, for three PRO-XTEN masked TCE programs. It’s a second pharma vote for the platform, and it comes from Vir’s CHD competitor.
This Substack is reader-supported. To receive new post...
This Substack is reader-supported. To receive new posts and support my work, consider becoming a free or paid subscriber.
The Event: In August I wrote that the dilution is the thesis. Today’s 10-Q puts a number on how much room that machin...
Viking started its oral Phase 3 on schedule with lower doses aimed at the vomiting problem. A footnote also confirms the ‘weekly pill’ I’d been counting on is actually a daily pill.
This Substack is reader-supported. To receive new posts a...
VQW-765 missed its Phase III primary endpoint in social anxiety disorder by a margin of 0.4 points out of 100. One speculative catalyst is gone, and the whole 2026 story now rests on Thetis.
This Substack is reader-supported. To receive ne...
Subscribers, engagement, traffic and sponsorship for Biotech Distilled.
| Subscribers | Engagement | 79 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
How this newsletter ranks in the official Substack charts.
| #41 |
The writers behind this newsletter.
PhD in Medicinal Chemistry. Senior Patent Agent. Extensive experience evaluating drug discovery programs — from molecular mechanism to clinical plausibility.
You can find recent issues that have been published by Biotech Distilled on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Biotech Distilled, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Biotech Distilled as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Biotech Distilled using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Biotech Distilled. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.